Imaging
Imaging covers the ways of seeing cancer inside the body without cutting, from X-rays to tracers that light up a single protein.
Anatomic imaging (CT, MRI, ultrasound) shows shape and size. Functional and molecular imaging (PET, SPECT) shows biology: glucose uptake, receptor expression, immune cell presence. The frontier is target-specific PET that predicts whether a targeted drug will work, and imaging that reads out treatment response within days rather than months.
Software that reads scans alongside radiologists, catching cancers earlier and predicting who is at risk.
Aidoc CARE is a single foundation model behind many FDA-cleared triage alerts in emergency radiology.
CAIX PET is a scan using an antibody against a protein almost unique to clear-cell kidney cancer, to tell cancer from benign kidney lumps without a biopsy.
A CT scan is a fast 3D X-ray that shows the size and shape of tumours and whether they have spread.
A model pretrained on 148,000 CT scans to segment organs and triage findings.
FAPI PET is a PET scan that lights up the scaffolding around almost any solid tumour, including cancers the standard sugar scan misses.
FDG PET is the standard PET scan. A radioactive sugar shows which tissues are burning glucose fast, which most cancers do.
Injecting a dye that makes tumour glow so the surgeon can see exactly where to cut.
HER2 PET is a PET scan using radiolabelled trastuzumab or smaller HER2 binders to map HER2 across all metastases at once.
Independent radiologists who re-read every scan in a trial the same way, so response rates mean the same thing across hospitals.
PET scans built from radiolabelled antibodies or their fragments, to see any protein an antibody can reach, including immune cells inside tumours.
A yearly low-radiation CT scan for current and former heavy smokers that finds lung cancer early enough to cure it.
Low-dose breast X-ray used for screening. Newer 3D versions find more cancers with fewer false alarms.
The particle accelerators and shielded robotic chemistry boxes that make PET tracers in hospital basements and commercial pharmacies.
Adaptations of Meta's Segment Anything model that outline tumours and organs on any scan with a click.
Merlin is a model trained on 15,000 CT scans with their reports that can find and describe hundreds of findings.
A noradrenaline look-alike that neuroblastoma cells swallow: labelled with a small amount of radioactivity it shows the tumour on a scan; with a large amount it treats it.
Uses magnets and radio waves, no radiation, to give very detailed pictures of soft tissue such as brain, breast, liver, and prostate.
An MRI before biopsy that finds the cancers that matter and lets many men skip biopsy altogether.
Nuclear medicine hardware means the scanners themselves: PET/CT, SPECT/CT, and new total-body PET that images the whole body at once.
Dyes that glow under special light, so surgeons can see tumour edges and nerves in the operating theatre.
A PET tracer that measures how much of the DNA repair enzyme PARP a tumour has, to predict response to PARP inhibitors.
A scan that shows where a radioactive tracer accumulates, so it images what tumours are doing rather than what they look like.
Making PSMA, FDG, and new tracers under drug-manufacturing rules and delivering them daily.
Scan after two cycles of chemotherapy; if the tumour has gone dark, give less treatment, and if not, give more. Hodgkin lymphoma pioneered this.
PET and CT in one machine, so hot spots on the PET are pinned to exact locations on the CT.
PET combined with MRI instead of CT, giving biology plus the best soft-tissue detail, at lower radiation dose.
A prostate-cancer-specific PET scan that finds spread far earlier than CT or bone scan, and tells you whether a matched radioactive drug will work.
Brighter, longer-lasting fluorescent particles and targeted microbubbles that make tumours visible during surgery or on an ultrasound scan.
An open generalist model that answers questions about 2D and 3D scans.
The factories and courier routes that make and deliver short-lived radioactive tracers to hospitals within hours.
A PET scan using a radioactive hormone mimic that lights up neuroendocrine tumours and shows whether the matching radioactive treatment will work.
SPECT and the bone scan are an older type of nuclear scan, still used for bone metastases and to check where a radioactive drug went after treatment.
Scanners sensitive enough to image the whole body in seconds at a fraction of the radiation dose, which raises the question of whether healthy people should be scanned at all.
An experimental PET scan that shows whether a tumour carries the TROP2 protein, so doctors could pick the right ADC before giving it.
Ultrasound uses sound waves to make live pictures; it is cheap, safe, and used to guide needles into lumps.
Whole-body MRI is an MRI of the entire body without radiation, used to find spread in myeloma and to screen people with high inherited cancer risk.